Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BI 397

Known as: BI397 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Teicoplanin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
16S rRNA methylase gene, together with quinolone resistance determinant aac(6')-Ib-cr, in a Serratia marcescens isolate from China.
Anderegg TR, Biedenbach DJ, Jones RN. Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an… Expand
  • table 1
Highly Cited
2012
Highly Cited
2012
Glycopeptide Antibiotics
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. Emergence of resistance in… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table II
Review
2006
Review
2006
Dalbavancin: a review for dermatologists.
Most complicated skin and skin structure infections (cSSSI) are caused by Staphylococcus aurens (SA) and streptococcus (SC). More… Expand
2005
2005
Meningitis Due to Vancomycin-Resistant Enterococcus faecium Successfully Treated with Combined Intravenous and Intraventricular Chloramphenicol
We report a case of meningitis caused by vancomycin-resistant Enterococcus faecium (VREF) that was succesfully treated with… Expand
  • table 1
Review
2004
Review
2004
Glycopeptide antibiotics: from conventional molecules to new derivatives.
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. Emergence of resistance in… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table II
2004
2004
Evaluations of Dalbavancin Activity and Spectrum Tested Against European Isolates
Background: Ongoing development of novel resistances (R) and the increased frequency of currently characterized R, requires the… Expand
  • table 1
2003
2003
Initial Quality Control Evaluations for Susceptibility Testing of Dalbavancin (BI397), an Investigational Glycopeptide with Potent Gram-Positive Activity
As gram-positive pathogens have acquired resistances to traditional therapeutic agents and multidrug-resistant clones have spread… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE